May 2026
📣 VC round data is live. Check it out!
Largest DeepTech Public Companies in Spain
Benchmark revenue and EBITDA valuation multiples for public comps like
Grenergy Renovables, Solaria Energia, Oryzon Genomics, Atrys Health and Pangaea Oncology.
 | Grenergy Renovables SA is a Spanish Independent Power Producer (IPP) that designs, develops, and executes renewable energy plants on a large scale. Its services are divided into different activities including the promotion, commercialization, and construction of renewable energy installations, the production and commercialization of electric energy as well as any complementary activities, and the management and operation of renewable energy installations. It operates in segments that include: Development and Construction which also generates key revenue for the company; Energy; Commercialization, and Services. Geographically, the company generates revenue from Chile, Mexico, Peru, Argentina, Colombia, Spain and other regions. | $153 | +89% | $4B | $5B | 8.6x | 31.7x | ||
| Solaria Energia y Medio Ambiente SA is a solar photovoltaic (PV) power generation company. It is also engaged in the solar power plant custom operation and maintenance services and development and management of PV projects. The company owns, manages and operates PV plants in Spain, Italy, Uruguay, Greece and Brazil. | $28 | +223% | $4B | $5B | 15.3x | 17.3x | ||
| Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases. | $4 | +16% | $279M | $255M | — | (44.7x) | ||
| Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. | $3 | +2% | $244M | $529M | 2.8x | 19.5x | ||
| Pangaea Oncology SA is a medical services company. The company provides a wide range of services to cancer patients, as well as global pharmaceutical and biotech clients, in the fields of molecular diagnostics, clinical trials, in vitro drug profiling, dx platform validation, and biomarker discovery. The company has aggregated its operations into two segments, Clinical Care division and Diagnostic and Research and Development services division. Clinical Care division delivers medical oncology services and related activities. Diagnostic and Research and Development services division provides diagnostic and in-vitro services. | $2 | -8% | $66M | $69M | 4.1x | (62.9x) | ||
| Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific. | $3 | -62% | $48M | $267M | 1.6x | (7.8x) | ||
| Energia Innovacion Y Desarrollo Fotovoltaico SA is a company specialized in photovoltaic solar energy projects. It offers engineering services, energy consulting, and installation of low and medium voltage. It is engaged in self-consumption photovoltaic installations for companies. Some of its projects are Generation park-Pulpi I, Fricosa, Barcia pipes, Peregrin One Garlic among others. The company currently has two Operating Segments: Generation and self-consumption, and Marketing. | $1 | -87% | $34M | $60M | 0.4x | (1.4x) | ||
| Median | $3 | +2% | $244M | $267M | 3.5x | (1.4x) |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.